Skip to content

A study on the feasibility and benefits of online speech-language therapy for patients with primary progressive aphasia.

A study on the feasibility and benefits of online speech-language therapy for patients with primary progressive aphasia. - PPA-OST Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057337
Enrollment
10
Registered
2025-03-19
Start date
2025-03-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary progressive aphasia

Interventions

Intervention period: Up to three years Intervention frequency: Forty minutes per session, once per month

Sponsors

Osaka university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged 20 years or older at the time of obtaining consent. Individuals who wish to receive remote ST. Meets the diagnostic criteria for PPA (Gorno-Tempini et al., Neurology, 2011).

Exclusion criteria

Exclusion criteria: Individuals with a history of organic brain diseases (including a clear history of cerebral infarction, Parkinson's disease, or related disorders) or those diagnosed with a mental disorder. Individuals with substance-related disorders (e.g., drug dependence). Individuals with a severe illness or a history of such an illness, whom the sub-investigator deems unsuitable for participation in this study. Individuals suspected of having severe hearing loss or visual impairment. Individuals whom the sub-investigator deems unsuitable for participation in this study for other reasons.

Design outcomes

Primary

MeasureTime frame
Feasibility of introducing online ST Annual changes in performance on language training tasks.

Secondary

MeasureTime frame
Annual changes in cognitive function (Mini-Mental State Examination, Raven's Coloured Progressive Matrices) and language function (WAB Aphasia Battery).

Countries

Japan

Contacts

Public ContactAkihiro Takasaki

Graduate School of Medicine, Osaka University Department of Psychiatry, Course of Integrated Medicine, Division of Internal Medicine.

atakasaki@psy.med.osaka-u.ac.jp06-6879-3051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026